Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Resveratrol Modulation of Apoptosis and Cell Cycle Response to Cisplatin in Head and Neck Cancer Cell Lines
Marinela Bostan, Mirela Mihăilă, Georgiana Gabriela Petrică-Matei, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 12, pp. 6322-6322
Open Access | Times Cited: 21

Showing 21 citing articles:

Cisplatin for cancer therapy and overcoming chemoresistance
Ranmali Ranasinghe, Michael L. Mathai, Anthony Zulli
Heliyon (2022) Vol. 8, Iss. 9, pp. e10608-e10608
Open Access | Times Cited: 65
Resveratrol as a Promising Nutraceutical: Implications in Gut Microbiota Modulation, Inflammatory Disorders, and Colorectal Cancer
Vidhya Prakash, Chinchu Bose, Damu Sunilkumar, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 6, pp. 3370-3370
Open Access | Times Cited: 16
Effects and mechanisms of resveratrol for prevention and management of cancers: An updated review
Si-Xia Wu, Ruo-Gu Xiong, Siyu Huang, et al.
Critical Reviews in Food Science and Nutrition (2022) Vol. 63, Iss. 33, pp. 12422-12440
Closed Access | Times Cited: 52
Curcumin- and resveratrol-co-loaded nanoparticles in synergistic treatment of hepatocellular carcinoma
Yongshun Zheng, Ran Jia, Jun Li, et al.
Journal of Nanobiotechnology (2022) Vol. 20, Iss. 1
Open Access | Times Cited: 45
Systematic Review of Gossypol/AT-101 in Cancer Clinical Trials
Olga Renner, Mascha Mayer, Christian Leischner, et al.
Pharmaceuticals (2022) Vol. 15, Iss. 2, pp. 144-144
Open Access | Times Cited: 39
Distinct mechanisms by which Nrf1 and Nrf2 as drug targets contribute to the anticancer efficacy of cisplatin on hepatoma cells
Reziyamu Wufuer, Keli Liu, Jing Feng, et al.
Free Radical Biology and Medicine (2024) Vol. 213, pp. 488-511
Closed Access | Times Cited: 7
Decavanadate Compound Displays In Vitro and In Vivo Antitumor Effect on Melanoma Models
Amine Essid, Ines ELBini-Dhouib, Regaya Ksiksi, et al.
Bioinorganic Chemistry and Applications (2025) Vol. 2025, Iss. 1
Open Access
Resveratrol in breast cancer treatment: from cellular effects to molecular mechanisms of action
Mitra Behroozaghdam, Maryam Dehghani, Amirhossein Zabolian, et al.
Cellular and Molecular Life Sciences (2022) Vol. 79, Iss. 11
Closed Access | Times Cited: 33
Studies Regarding the Pharmaceutical Potential of Derivative Products from Plantain
Marilena-Gabriela Olteanu Zaharie, Nicoleta Radu, Lucia Pîrvu, et al.
Plants (2022) Vol. 11, Iss. 14, pp. 1827-1827
Open Access | Times Cited: 13
Cell Culture Model Evolution and Its Impact on Improving Therapy Efficiency in Lung Cancer
Viviana Roman, Mirela Mihăilă, Nicoleta Radu, et al.
Cancers (2023) Vol. 15, Iss. 20, pp. 4996-4996
Open Access | Times Cited: 6
Effect and mechanism of resveratrol on ferroptosis mediated by p53/SLC7A11 in oral squamous cell carcinoma
Chen Mao, L. Gong, W.Y. Kang
BMC Oral Health (2024) Vol. 24, Iss. 1
Open Access | Times Cited: 1
Anticancer Activity of Some Ruthenium(III) Complexes with Quinolone Antibiotics: In Vitro Cytotoxicity, Cell Cycle Modulation, and Apoptosis-Inducing Properties in LoVo Colon Cancer Cell Line
Mirela Mihăilă, Camelia Mia Hotnog, Marinela Bostan, et al.
Applied Sciences (2021) Vol. 11, Iss. 18, pp. 8594-8594
Open Access | Times Cited: 14
Development and Evaluation of Docetaxel-Loaded Nanostructured Lipid Carriers for Skin Cancer Therapy
Florentina-Iuliana Cocoș, Valentina Anuța, Lăcrămioara Popa, et al.
Pharmaceutics (2024) Vol. 16, Iss. 7, pp. 960-960
Open Access | Times Cited: 1
Non-cytotoxic levels of resveratrol enhance the anticancer effects of cisplatin by increasing the methyltransferase activity of CARM1 in human cancer cells
Xiao-Yun Zhao, Qiu-Hua Zhong, Heng Wee Tan, et al.
Phytomedicine (2024) Vol. 135, pp. 156127-156127
Closed Access | Times Cited: 1
Jie Geng Tang reverses cisplatin resistance through the Nrf2 pathway in lung cancer
Jing Zhao, Manting Hou, Kaixin Ding, et al.
Journal of Pharmacy and Pharmacology (2023) Vol. 75, Iss. 6, pp. 784-805
Closed Access | Times Cited: 4
Novel Bovine Serum Albumin-Decorated–Nanostructured Lipid Carriers Able to Modulate Apoptosis and Cell-Cycle Response in Ovarian, Breast, and Colon Tumoral Cells
Robert Țincu, Mirela Mihăilă, Marinela Bostan, et al.
Pharmaceutics (2023) Vol. 15, Iss. 4, pp. 1125-1125
Open Access | Times Cited: 4
The Employment of Genera Vaccinium, Citrus, Olea, and Cynara Polyphenols for the Reduction of Selected Anti-Cancer Drug Side Effects
Jessica Maiuolo, Vincenzo Musolino, Micaela Gliozzi, et al.
Nutrients (2022) Vol. 14, Iss. 8, pp. 1574-1574
Open Access | Times Cited: 5
How far have we come in our efforts to apply personalized therapy for lung cancer at bedside?
Hyun Soo Kim, In Kyoung Kim, Saemi Lee, et al.
Molecular & Cellular Toxicology (2024)
Closed Access
Chemotherapeutics
Y Clément, Mario A. Shields
Elsevier eBooks (2023), pp. 331-354
Closed Access | Times Cited: 1
Role of LONP2 in head and neck squamous cell carcinoma
Xiaobo Cui, Yali Zhang, Le Zhang, et al.
Gene (2022) Vol. 851, pp. 147033-147033
Closed Access | Times Cited: 2
Distinct mechanisms by which antioxidant transcription factors Nrf1 and Nrf2 as drug targets contribute to the anticancer efficacy of Cisplatin on hepatoma cells
Reziyamu Wufuer, Keli Liu, Jingfeng, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access
Page 1

Scroll to top